# CURRENT_OPERATIONAL.md — Knee-OA independent review preparation

> **STATUS:** PRODUCT-OWNER FUNCTIONAL/DESIGN ACCEPTANCE RECORDED / INDEPENDENT MULTI-AXIS REVIEW PREPARATION ACTIVE.
> **Updated:** 2026-09-11 Asia/Nicosia.
> **Canonical home:** `athpapachr-cmd/osteoporosis`.
> **Verified main:** `d9f312f6d2d596ec0bd4f35f6de56ad98dc34b37`.
> **Pinned accepted candidate branch/head:** `feat/physio-referral-knee-oa-prototype-v1-2026-09-11` @ `6539351c592c1dc3e49931057b63925dea3cb94d`.
> **Tested substantive implementation head:** `243095ca9545bd2f96be8986520aeae8c3551c27`.
> **Review-preparation branch:** `review/physio-referral-knee-oa-independent-v1-2026-09-11`.
> **ACTIVE WRITER:** review-preparation docs only; prototype/runtime/evidence contracts are pinned read-only.
> **PR / merge / deploy / production smoke authority:** NONE.
> **Real-patient use / production integration:** NOT AUTHORIZED.

## 1. Product-owner acceptance now recorded

The product owner reviewed the refined Knee-OA prototype direction and explicitly stated that the design is liked and authorized progression. This is accepted as product-owner design/functional-direction approval of the pinned Step-6A candidate, not as clinical validation, accessibility validation, commercial validation or release authority.

The accepted candidate includes progressive-disclosure pain location (including pes-anserine region), weakness specificity/atrophy context, stiffness pattern/duration, fixed flexion deformity as a separate examination finding, compact summaries, evidence interaction, live deterministic referral and retained CU-1 safety authority.

## 2. Exact next gate

Prepare a reviewer-neutral packet against the pinned candidate above. The reviewer must not inherit the author's conclusions as truth and must independently examine four axes:

```text
clinical / evidence integrity
physiotherapy usefulness and professional autonomy
UX / accessibility / cognitive load
commercial value / retention / willingness-to-pay logic
```

A separate source-to-claim audit is also required for exact evidence fidelity and locator precision.

## 3. Review principles

The independent reviewer must explicitly answer:

- what is clinically wrong, overstated, missing or potentially misleading;
- what should be removed rather than added;
- whether the referral is useful to a physiotherapist without becoming prescriptive;
- whether progressive disclosure actually preserves speed;
- whether evidence cues are understandable without training;
- whether the product creates recurring value at approximately €9.99/month;
- which findings are blockers before expansion to a second diagnosis;
- which findings can wait until later productization.

No score may conceal material safety/evidence concerns. Any `PASS` requires a written material-open-finding statement.

## 4. HOLD

No new diagnosis, feature expansion, production CU-1 rewrite, public hosting, auth/billing, merge or deployment while the independent review candidate is being pinned and reviewed. Review findings may trigger a bounded replan; they do not authorize implementation automatically.
